Abstract
Due to the ineffectiveness, side effects, and high cost of conventional drugs, medicinal plants grabbed the attention to treat diabetes, which has been a global health concern nowadays. Therefore, this study aims to investigate the antidiabetic potentialities of bottle gourd (Lagenaria siceraria) fruits in in vivo, in vitro, and in silico methods. For the in vivo assessment, alloxan-induced diabetic rats were fed food mixed with bottle gourd powder for 21 days. For the in vitro assessment, the alpha-amylase inhibitory assay was used to determine the antidiabetic properties of an ethanolic extract of L. siceraria. For the in silico assessment, ten compounds from L. siceraria were selected as found in literature, upon which molecular docking studies were conducted to evaluate the binding affinity of these compounds with Human CYP3A4 (bound to metformin) and Human dipeptidyl peptidase-IV proteins. Bottle gourd powder showed slower activity to reverse the disease condition in animal model, but it has appeared to be safe for both the kidney and liver. Ethanolic extract of L. siceraria exerted a dose-dependent increase in percent (%) inhibition of alpha-amylase enzyme as compared to standard acarbose. In the molecular docking study, most of the targeted compounds showed better affinity toward selected protein compared to metformin hydrochloride. In addition, most of the compounds were found free of toxicities. Therefore, it is concluded that bottle gourd powder showed potential as an antidiabetic agent but further studies should be conducted on different extracts of L. siceraria to establish bottle gourd as a novel antidiabetic agent to treat diabetes mellitus.
References
Abdin, M., Arya, L., Saha, D., Sureja, A., Pandey, C., & Verma, M. (2014). Population structure and genetic diversity in bottle gourd [Lagenaria siceraria (Mol.) Standl.] germplasm from India assessed by ISSR markers. Plant Systematics and Evolution, 300(4), 767–773.
Agrawal, S., Mohale, D., Ghule, B. v, Saoji, A., & Yeole, P. (2008). Studies on the antihyperlipidemic activity of flavonoidal fraction of Lagenaria siceraria. International Journal of Chemical Sciences, 6, 751–760.
Ahire, E., Sonawane, V., Surana, K., & Talele, G. (2021). Drug discovery, drug-likeness screening, and bioavailability: Development of drug-likeness rule for natural products. In Applied Pharmaceutical Practice and Nutraceuticals. Apple Academic Press.
Akash, S., Chakma, U., Chandro, A., Matin, M., & Howlader, D. (2021). The computational screening of inhibitor for black fungus and white fungus by D-glucofuranose derivatives using in silico and SAR study. Organic Communications, 14(4), 336–353.
Beevy, S., & Kuriachan, P. (1996). Chromosome numbers of south Indian Cucurbitaceae and a note on the cytological evolution in the family. Journal of Cytology and Genetics, 31, 65–71.
Bhattacharya, S., & Das, B. (2012). Anti-diabetic activity of Lagenaria siceraria pulp and seed extract in normal and alloxan-induced diabetic rats. International Journal of Pharmaceutical Sciences and Research, 3(9), 3362.
Borah, P., Hazarika, S., Deka, S., & al, et. (2020). Application of advanced technologies in natural product research: A review with special emphasis on ADMET profiling. Current Drug Metabolism, 21(10), 751–767.
Chatterjee, J., Rechenmacher, F., & Kessler, H. (2013). N‐methylation of peptides and proteins: An important element for modulating biological functions. Angewandte Chemie International Edition, 52(1), 254–269.
Cheng, F., Li, W., Liu, G., & Tang, Y. (2013). In silico ADMET prediction: Recent advances, current challenges and future trends. Current Topics in Medicinal Chemistry, 13(11), 1273–1289.
Cutler, H., & Whitaker, T. (1967). Cucurbits from the Tehuacan Caves. University of Texas Press.
Daoud, N., Borah, P., Deb, P., & al, et. (2021). ADMET profiling in drug discovery and development: Perspectives of in silico, in vitro and integrated approaches. Current Drug Metabolism, 22(7), 503–522.
Dineshkumar, B., Mitra, A., & Manjunatha, M. (2010). A comparative study of alpha amylase inhibitory activities of common anti-diabetic plants at Kharagpur 1 block. International Journal of Green Pharmacy (IJGP), 4(2).
Duke, J. (1992). Handbook of Biologically Active Phytochemicals and Their Activities. CRC Press, Inc.
Erejuwa, O. (2012). Oxidative stress in diabetes mellitus: Is there a role for hypoglycemic drugs and/or antioxidants. Oxidative Stress and Diseases, 217, 246.
Etxeberria, U., de la Garza, A., Campión, J., Martínez, J., & Milagro, F. (2012). Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase. Expert Opinion on Therapeutic Targets, 16(3), 269–297.
Federiuk, I., Casey, H., Quinn, M., Wood, M., & Ward, K. (2004). Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: Route of administration, pitfalls, and insulin treatment. CompMed, 54(3), 252–257.
Friesner, R., Murphy, R., Repasky, M., & al, et. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein− ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196.
Funke, I., & Melzig, M. (2006). Traditionally used plants in diabetes therapy: Phytotherapeutics as inhibitors of alpha-amylase activity. Revista Brasileira de Farmacognosia, 16, 1–5.
Gohlke, H., & Klebe, G. (2002). Approaches to the description and prediction of the binding affinity of small‐molecule ligands to macromolecular receptors. Angewandte Chemie International Edition, 41(15), 2644–2676.
Guo, Z., Sevrioukova, I. F., Denisov, I. G., Zhang, X., Chiu, T.-L., Thomas, D. G., Hanse, E. A., Cuellar, R. A. D., Grinkova, Y. V., Langenfeld, V. W., Swedien, D. S., Stamschror, J. D., Alvarez, J., Luna, F., Galván, A., Bae, Y. K., Wulfkuhle, J. D., Gallagher, R. I., Petricoin, E. F., … Potter, D. A. (2017). Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria. Cell Chemical Biology, 24(10), 1259-1275.e6. https://doi.org/10.1016/j.chembiol.2017.08.009
Halgren, T. (1996). Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. Journal of Computational Chemistry, 17(5–6), 490–519.
Hann, M., Leach, A., & Harper, G. (2001). Molecular complexity and its impact on the probability of finding leads for drug discovery. Journal of Chemical Information and Computer Sciences, 41(3), 856–864.
Hanwell, M., Curtis, D., Lonie, D., Vandermeersch, T., Zurek, E., & Hutchison, G. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4(1), 1–17.
Herman, W. (2017). The global burden of diabetes: An overview. Diabetes Mellitus in Developing Countries and Underserved Communities, 1–5.
Hu, F. (2011). Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care, 34(6), 1249–1257.
Juee, L., & Naqishbandi, A. (2020). Calabash (Lagenaria siceraria) potency to ameliorate hyperglycemia and oxidative stress in diabetes. Journal of Functional Foods, 66, 103821.
Kortemme, T., & Baker, D. (2002). A simple physical model for binding energy hot spots in protein–protein complexes. Proceedings of the National Academy of Sciences, 99(22), 14116–14121.
Kumer, A., Chakma, U., Rana, M. M., Chandro, A., Akash, S., Elseehy, M. M., Albogami, S., & El-Shehawi, A. M. (2022). Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study. Molecules, 27(12), 3694. https://doi.org/10.3390/molecules27123694
Lionta, E., Spyrou, G., Vassilatis, D., & Cournia, Z. (2014). Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances. Current Topics in Medicinal Chemistry, 14(16), 1923–1938. https://doi.org/10.2174/1568026614666140929124445
Lipinski, C. (2004). Lead-and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337–341.
Liu, S., An, J., Zhao, J., Zhao, S., Lv, H., & Wang, S. (2021). Drug-Target Interaction Prediction Based on Multisource Information Weighted Fusion. Contrast Media & Molecular Imaging, 2021.
Marles, R., & Farnsworth, N. (1995). Antidiabetic plants and their active constituents. Phytomedicine, 2(2), 137–189.
Mashilo, J., Shimelis, H., & Odindo, A. (2017). Phenotypic and genotypic characterization of bottle gourd [Lagenaria siceraria (Molina) Standl.] and implications for breeding: A Review. Scientia Horticulturae, 222, 136–144.
Milne, G. (2010). Software review of ChemBioDraw 12.0.
Minocha, S. (2015). An overview on Lagenaria siceraria (bottle gourd). Journal of Biomedical and Pharmaceutical Research, 4(3), 4–10.
Morimoto, Y., Maundu, P., Fujimaki, H., & Morishima, H. (2005). Diversity of landraces of the white-flowered gourd (Lagenaria siceraria) and its wild relatives in Kenya: Fruit and seed morphology. Genetic Resources and Crop Evolution, 52(6), 737–747.
Nabi, S., Kasetti, R., Sirasanagandla, S., Tilak, T., Kumar, M., & Rao, C. (2013). Antidiabetic and antihyperlipidemic activity of Piper longum root aqueous extract in STZ induced diabetic rats. BMC Complement Alternative Medicine, 13(1), 1–9.
Nadkarni, K. (1954). Indian Materia Medica, Bombay Popular Prakashan. Mumbai VI.
Nehra, B., Mathew, B., & Chawla, P. (2022). A Medicinal Chemist’s Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents. Current Topics in Medicinal Chemistry, 22(6), 493–528.
Pantsar, T., & Poso, A. (2018). Binding affinity via docking: Fact and fiction. Molecules, 23(8), 1899.
Pires, D. V., Blundell, T., & Ascher, D. (2015). pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072.
Ramen, C., & Manas, C. (2013). An overview on management of diabetic dyslipidemia. Journal of Diabetes and Endocrinology, 4(3), 27–36.
Rao, M., Sreenivasulu, M., Chengaiah, B., Reddy, K., & Chetty, C. (2010). Herbal medicines for diabetes mellitus: A review. International Journal of PharmTech Research, 2(3), 1883–1892.
Rashid, M. (2020). Design, synthesis and ADMET prediction of bis-benzimidazole as anticancer agent. Bioorganic Chemistry, 96, 103576. https://doi.org/10.1016/j.bioorg.2020.103576
Sakib, R., Prottay, A., Rahman, N., Rabbani, G., & Akter, K. (2019). In-Silico Molecular Docking Study of Afzelin and Its Derivatives Against 6M0j For Treatment of COVID-19.
Schulz-Gasch, T., & Stahl, M. (2003). Binding site characteristics in structure-based virtual screening: Evaluation of current docking tools. Journal of Molecular Modeling, 9, 47–57.
Sharmin, R., Khan, M., Akhtar, M., & al, et. (2013). Hypoglycemic and hypolipidemic effects of cucumber, white pumpkin and ridge gourd in alloxan induced diabetic rats. Journal of Scientific Research, 5(1), 161–170.
Shi, S. (2014). Biologics: An update and challenge of their pharmacokinetics. Current Drug Metabolism, 15(3), 271–290.
Sutton, J. M., Clark, D. E., Dunsdon, S. J., Fenton, G., Fillmore, A., Harris, N. V., Higgs, C., Hurley, C. A., Krintel, S. L., MacKenzie, R. E., Duttaroy, A., Gangl, E., Maniara, W., Sedrani, R., Namoto, K., Ostermann, N., Gerhartz, B., Sirockin, F., Trappe, J., … Baeschlin, D. K. (2012). Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters, 22(3), 1464–1468. https://doi.org/10.1016/j.bmcl.2011.11.054
Tallei, T., Tumilaar, S., Niode, N., & al, et. (2020). Potential of plant bioactive compounds as SARS-CoV-2 main protease (M pro) and spike (S) glycoprotein inhibitors: A molecular docking study. Scientifica (Cairo), 2020.
Toma, A. (2013). Recent advances on novel dual-acting peroxisome proliferator-activated receptor alpha and gamma agonists. International Journal of Pharmaceutical Sciences and Research, 4(5), 1644.
Turner, R., Cull, C., Frighi, V., & Holman, R. (1999). Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). JAMA, 281(21), 2005–2012.
Upaganlawar, A., & Balaraman, R. (2009). Bottle gourd (Lagenaria siceraria) A vegetable food for human health-a comprehensive review. Pharmacol Online, 1, 209–226.
van Wyk, B., & Gericke, N. (2000). People’s Plants: A Guide to Useful Plants of Southern Africa. Briza publications.
Walters, W. (2012). Going further than Lipinski’s rule in drug design. Expert Opin Drug Discov, 7(2), 99–107.
Wu, L., & Parhofer, K. (2014). Diabetic dyslipidemia. Metabolism, 63(12), 1469–1479.
Zimmet, P., Magliano, D., Herman, W., & Shaw, J. (2014). Diabetes: A 21st century challenge. Lancet Diabetes Endocrinol, 2(1), 56–64.
Recommended Citation
Sultana, Arifa; Aktar, Fahima; Noushin, Fabiha; Wahed, Mariam; Chowdhury, Jakir Ahmed; Chowdhury, Abu Asad; Kabir, Shaila; and Amran, Md. Shah
(2026)
"The Exploration of the Antidiabetic Potentialities of Bottle gourd (Lagenaria siceraria) Fruits through In vivo, In vitro and In silico Approaches,"
Pharmaceutical Sciences and Research: Vol. 12:
No.
3, Article 5.
DOI: 10.7454/psr.v12i3.1412
Available at:
https://scholarhub.ui.ac.id/psr/vol12/iss3/5
Included in
Alternative and Complementary Medicine Commons, Natural Products Chemistry and Pharmacognosy Commons, Other Pharmacy and Pharmaceutical Sciences Commons, Pharmaceutics and Drug Design Commons


